In a general population survey (N = 314), 79 percent of respondents stated
that they would take a hypothetical genetic test to predict whether they wi
ll eventually develop Alzheimer's disease. The proportion fell to 45 percen
t for a "partially predictive" test (which had a one in ten chance of being
incorrect). Inclination to obtain testing was similar across age groups. R
espondents were willing to pay $324 for the completely predictive test. Res
pondents stated that if they tested positive, they would sign advance direc
tives (84 percent), get their finances in order (74 percent), and purchase
long-term care insurance (69 percent). Only a third of respondents expresse
d concern about confidentiality. The results suggest that people value gene
tic testing for personal and financial reasons, but they also underscore th
e need to counsel potential recipients carefully about the accuracy and imp
lications of test information.